These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 22999396

  • 1. Effects of preoperative sublingual misoprostol on uterine tone during isoflurane anesthesia for cesarean section.
    El Tahan MR, Warda OM, Rashad A, Yasseen AM, Ramzy EA, Ahmady MS, Diab DG, Matter MK.
    Rev Bras Anestesiol; 2012; 62(5):625-35. PubMed ID: 22999396
    [Abstract] [Full Text] [Related]

  • 2. Effect of sublingual misoprostol versus intravenous oxytocin on reducing blood loss at cesarean section in Nigeria: a randomized controlled trial.
    Owonikoko KM, Arowojolu AO, Okunlola MA.
    J Obstet Gynaecol Res; 2011 Jul; 37(7):715-21. PubMed ID: 21375669
    [Abstract] [Full Text] [Related]

  • 3. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section.
    Vimala N, Mittal S, Kumar S.
    Int J Gynaecol Obstet; 2006 Feb; 92(2):106-10. PubMed ID: 16343498
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of sublingual misoprostol versus intravenous oxytocin in reducing bleeding after caesarean section.
    Eftekhari N, Doroodian M, Lashkarizadeh R.
    J Obstet Gynaecol; 2009 Oct; 29(7):633-6. PubMed ID: 19757270
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Rectally administered misoprostol versus intravenous oxytocin infusion during cesarean delivery to reduce intraoperative and postoperative blood loss.
    Chaudhuri P, Banerjee GB, Mandal A.
    Int J Gynaecol Obstet; 2010 Apr; 109(1):25-9. PubMed ID: 20070961
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial.
    Blum J, Winikoff B, Raghavan S, Dabash R, Ramadan MC, Dilbaz B, Dao B, Durocher J, Yalvac S, Diop A, Dzuba IG, Ngoc NT.
    Lancet; 2010 Jan 16; 375(9710):217-23. PubMed ID: 20060162
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Randomized double-blind placebo-controlled trial of buccal misoprostol to reduce the need for additional uterotonic drugs during cesarean delivery.
    Hernández-Castro F, López-Serna N, Treviño-Salinas EM, Soria-López JA, Sordia-Hernández LH, Cárdenas-Estrada E.
    Int J Gynaecol Obstet; 2016 Feb 16; 132(2):184-7. PubMed ID: 26534874
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial.
    Borruto F, Treisser A, Comparetto C.
    Arch Gynecol Obstet; 2009 Nov 16; 280(5):707-12. PubMed ID: 19229549
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.